|
1
|
Saraswat M, Suryanarayana P, Reddy PY,
Patil MA, Balakrishna N and Reddy GB: Antiglycating potential of
Zingiber officinalis and delay of diabetic cataract in rats. Mol
Vis. 16:1525–1537. 2010.PubMed/NCBI
|
|
2
|
Pollreisz A and Schmidt-Erfurth U:
Diabetic cataract-pathogenesis, epidemiology and treatment. J
Ophthalmol. 2010:6087512010.PubMed/NCBI
|
|
3
|
Moreau KL and King JA: Protein misfolding
and aggregation in cataract disease and prospects for prevention.
Trends Mol Med. 18:273–282. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lupachyk S, Stavniichuk R, Komissarenko
JI, Drel VR, Obrosov AA, El-Remessy AB, Pacher P and Obrosova IG:
Na+/H+-exchanger-1 inhibition counteracts
diabetic cataract formation and retinal oxidative-nitrative stress
and apoptosis. Int J Mol Med. 29:989–998. 2012.PubMed/NCBI
|
|
5
|
Styskal J, Van Remmen H, Richardson A and
Salmon AB: Oxidative stress and diabetes: What can we learn about
insulin resistance from antioxidant mutant mouse models? Free Radic
Biol Med. 52:46–58. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tebay LE, Robertson H, Durant ST, Vitale
SR, Penning TM, Dinkova-Kostova AT and Hayes JD: Mechanisms of
activation of the transcription factor Nrf2 by redox stressors,
nutrient cues, and energy status and the pathways through which it
attenuates degenerative disease. Free Radic Biol Med. 88:108–146.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kowluru RA, Mishra M, Kowluru A and Kumar
B: Hyperlipidemia and the development of diabetic retinopathy:
Comparison between type 1 and type 2 animal models. Metabolism.
65:1570–1581. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Suryanarayana P, Saraswat M, Mrudula T,
Krishna TP, Krishnaswamy K and Reddy GB: Curcumin and turmeric
delay streptozotocin-induced diabetic cataract in rats. Invest
Ophthalmol Vis Sci. 46:2092–2099. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ooley C, Jun W, Le K, Kim A, Rock N,
Cardenal M, Kline R, Aldrich D and Hayes J: Correlational study of
diabeticretinopathy and hearing loss. Optom Vis Sci. 94:339–344.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kwon JW, Choi JA and Jee D: Matrix
metalloproteinase-1 and matrix metalloproteinase-9 in the aqueous
humor of diabetic macular edema patients. PLoS One.
11:01597202106.
|
|
11
|
Wojnar W, Kaczmarczyk-Sedlak I and Zych M:
Diosmin ameliorates the effects of oxidative stress in lenses of
streptozotocin-induced type 1 diabetic rats. Pharmacol Rep.
69:995–1000. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang J, Wang X, Vikash V, Ye Q, Wu D, Liu
Y and Dong W: ROS and ROS-mediated cellular signaling. Oxid Med
Cell Longev. 2016:43509652016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bresciani A, Missineo A, Gallo M,
Cerretani M, Fezzardi P, Tomei L, Cicero DO, Altamura S, Santoprete
A, Ingenito R, et al: Nuclear factor (erythroid-derived 2)-like 2
(NRF2) drug discovery: Biochemical toolbox to develop NRF2
activators by reversible binding of Kelch-like ECH-associated
protein 1 (KEAP1). Arch Biochem Biophys. 631:31–41. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Danielli NM, Trevisan R, Mello DF, Fischer
K, Deconto VS, da Silva Acosta D, Bianchini A, Bainy AC and Dafre
AL: Upregulating Nrf2-dependent antioxidant defenses in Pacific
oysters Crassostrea gigas: Investigating the Nrf2/Keap1 pathway in
bivalves. Comp Biochem Physiol C Toxicol Pharmacol. 195:16–26.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Singh RP, Staurenghi G, Pollack A, Adewale
A, Walker TM, Sager D and Lehmann R: Efficacy of nepafenac
ophthalmic suspension 0.1% in improving clinical outcomes following
cataract surgery in patients with diabetes: An analysis of two
randomized studies. Clin Ophthalmol. 11:1021–1029. 2017. View Article : Google Scholar : PubMed/NCBI
|
